Innoveren Scientific Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-4.8	-6.78	-33.2	-4.39	0	-16.23	-6.52	-2.94
Depreciation & Amortization	0.02	0.08	0.83	0.1	0.03	0.2	0.43	0
Share-Based Compensation	1.18	0	1.79	0	0.68	0.78	0.25	0.03
Other Operating Activities	-1.21	-0.88	14.9	0.75	-6.3	9.82	-0.15	0.14
Operating Cash Flow	-4.81	-7.26	-12.29	-3.54	-5.59	-5.43	-5.98	-2.76
Capital Expenditures	-0.01	-0	-0.02	-0.01	-0.02	-0.09	-0.01	-0.02
Acquisitions	0	0	-0.37	0	0	0.5	-1.15	0
Other Investing Activities	-	-	-	-0.01	-	-	-	-
Investing Cash Flow	-0.01	-0	-0.39	-0.02	-0.02	0.41	-1.16	-0.02
Dividends Paid	0	0	-0.01	0	0	0	0	0
Share Issuance / Repurchase	0	0	4.34	0	3.84	2.78	1.08	6.83
Debt Issued / Paid	3.27	4.64	3.88	3.39	-0.13	0.72	0.66	0
Other Financing Activities	-	2.84	5.84	-	1.25	0.83	0.28	0.03
Financing Cash Flow	3.27	7.48	14.04	3.39	4.96	4.34	2.03	6.86
Net Cash Flow	-1.55	0.22	1.35	-0.18	-0.65	-0.68	-5.11	4.08
Free Cash Flow	-4.82	-7.26	-12.31	-3.56	-5.61	-5.51	-5.99	-2.78
Free Cash Flow Margin	-298.95%	-337.57%	-147.50%	-45.11%	-2704.27%	-	-	-
Free Cash Flow Per Share	-33.06	-65.12	-127.76	-105.64	-292.91	-416.02	-547.26	-352.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).